Contoura Vision has resulted in patients vision better than 6/6 (or 20/20, the standardized normal vision) in multiple patients who were a part of evaluation by US FDA trials in attempt to validate the technology. Contoura Vision is the technology where consistent success beyond 20/20 vision has been achieved in the majority of patients. More than 40% of the patients that were evaluated were able to read one additional line on the visual acuity chart than that of a patient with 20/20 vision. Additionally, 13.5% could read two additional lines on the visual acuity chart.
Fewer visual disturbances such as glare, halos, ghost images, difficulty in night time driving and reading were also reported by many patients. Contoura vision exhibited superior quality of vision compared to LASIK and SMILE technology